{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-029599","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2026-06-22T20:35:33+00:00","discovered_at":"2026-06-22T20:37:00.260537+00:00","generated_at":"2026-06-22T20:37:40.107110+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aspire Biopharma stockholders approve three warrant-related proposals at special meeting","bullets":["Warrant Issuance Proposal: 1,742,683 for, 107,523 against, 4,818 withheld, 0 non-votes.","Share Adjustment Proposal: 1,745,709 for, 103,550 against, 5,764 withheld, 0 non-votes.","Exercise Price Adjustment Proposal: 1,739,702 for, 110,483 against, 4,839 withheld, 0 non-votes.","All proposals related to warrants on common stock (ASBP) and warrants (ASBPW) under terms of Warrant Agreement dated March 17, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-029599","json":"https://secwatch.observer/filing/0001493152-26-029599.json","markdown":"https://secwatch.observer/filing/0001493152-26-029599.md","text":"https://secwatch.observer/filing/0001493152-26-029599.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/0001493152-26-029599-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T20:37:40.107110+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ae4ea998c74dd0ef0aec46527716d6536774504f","claim":"Aspire Biopharma Holdings, Inc. shareholders approved To approve adjustment of number of shares of common stock issuable upon exercise of warrants (Share Adjustment Proposal) at the 2026-06-16 meeting.","evidence_excerpt":"The number of shares that voted for, against, and withheld from voting for this Share Adjustment Proposal is summarized in the table below: Votes Non-Votes 1,745,709 103,550 5,764 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/0001493152-26-029599-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-16"}],"fact_type":"shareholder_vote"},{"claim_id":"e5d8595cab5db66a864806f4431e77183cdda844","claim":"Aspire Biopharma Holdings, Inc. shareholders approved To approve voluntary adjustments to the exercise price of the warrants (Exercise Price Adjustment Proposal) at the 2026-06-16 meeting.","evidence_excerpt":"The number of shares that voted for, against, and withheld from voting for this Exercise Price Adjustment Proposal is summarized in the table below: Votes Non-Votes 1,739,702 110,483 4,839 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/0001493152-26-029599-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-16"}],"fact_type":"shareholder_vote"},{"claim_id":"ec20e0194efa959a9ccd2cb29b1e225b42997392","claim":"Aspire Biopharma Holdings, Inc. shareholders approved To authorize issuance of shares of common stock upon exercise of warrants (Warrant Issuance Proposal) at the 2026-06-16 meeting.","evidence_excerpt":"The number of shares that voted for, against, and withheld from voting for this Warrant Issuance Proposal is summarized in the table below: Votes Non-Votes 1,742,683 107,523 4,818 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/0001493152-26-029599-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}